Improved photosynthetic characteristics correlated with enhanced biomass in a heterotic F1 hybrid of maize (Zea mays L.)

Photosynthesis Research - Heterosis is a phenomenon wherein F1 hybrid often displays phenotypic superiority and surpasses its parents in terms of growth and agronomic traits. Investigations on the...     

Biosorption of Copper (II) by the Microorganisms Isolated from the Crude-Oil-Contaminated Soil

The objective of this study was to isolate and screen the highly efficient copper-removing microorganisms from the petroleum hydrocarbon (PH)-contaminated sites in the Amazonian rain forest in Ecuador. Two bacterial strains (strain UEAB3 and UEAB6) have shown 100% microbial resistance on the nutrient medium containing 100 mM of MgCl₂, FeCl₃, and Al₂(SO₄)₃ separately. Though these two strains were less tolerant of ZnCl₂ and CuSO₄.5H₂O, they have proven 100% resistance at the lower concentrations of these two metals. According to atomic absorption spectroscopy (AAS) analysis, the filamentous fungi (strains UEAFr and UEAFg) were significantly (p<0.05) effective at bacteria in the biosorption (97–100%) of copper (5 mg L^?1) over 7 d. As per 16/18S rDNA sequences, UEAB3, UEAB6, UEAFr, and UEAFg were Bacillus thuringiensis, Bacillus cereus, Geomyces pannorum, and Geomyces sp., respectively. From these results, it can be comprehensively concluded that the isolated microbial cultures had a capacity to remove the copper metal from the liquid medium.     

Molecular docking studies and in vitro screening of new dihydropyridine derivatives as human MRP1 inhibitors

The overexpression of multidrug resistance protein 1 (MRP1) by tumor cells results in multidrug resistance (MDR) to structurally unrelated anticancer drugs. Circumvention of MDR by combination of chemosensitizers with antitumor compounds is a new field of investigation in cancer chemotherapy. Much effort has been put-in recently to identify the modulators/inhibitors of MRP1 to overcome the MDR. 1,4-Dihydropyridine (DHP) derivatives are indicated to be a new class of MRP1 inhibitors in cancer treatment. Molecular docking studies were carried out on 48 newly synthesized DHP derivatives with the crystal structure of MRP1 to gain some structural insights on the binding mode and possible interactions with the active site of MRP1 (NBD1). The 10 top-ranked molecules were selectively evaluated, experimentally for their MRP1 inhibitory effect using the insect cell membrane MRP1 ATPase assay. The inhibitory capacity (IC(50) concentrations) of the test compounds was compared with the reported IC(50)- or the K(i)-concentrations for benzbromarone, a standard MRP1 inhibitor. Amongst the compounds tested, compounds IA(1) and IIA(5) were found to exhibit a potent MRP1 inhibitory action with IC(50) values of 20±4 and 14±2 μM (mean±SD), respectively as compared to benzbromarone (IC(50)=4 μM). The compound IIA(5), in particular was found to be more potent than IA(1) in accordance with the docking results. These new DHP derivatives possess promising characteristics for their development as MDR reversal agents.